Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?

Gestational diabetes mellitus (GDM) is a complication that increasingly affects pregnant women. Due to the risk of adverse outcomes in the mother as well as in the fetus which is caused by GDM, appropriate diagnosis and treatment is very essential. Nevertheless, it is important to find new, effectiv...

Full description

Saved in:
Bibliographic Details
Published inJournal of Diabetes Research Vol. 2019; no. 2019; pp. 1 - 5
Main Authors Sobota-Grzeszyk, Angelika, Szamatowicz, J., Kuźmicki, Mariusz
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 2019
Hindawi
John Wiley & Sons, Inc
Hindawi Limited
Wiley
Subjects
Acids
Blood pressure
Cesarean section
Cholesterol
Development and progression
Dextrose
Diabetes in pregnancy
Fasting
Fetuses
Gestational diabetes
Glucose
Health aspects
Hypertension
Inositol
Insulin
Insulin resistance
Intensive care
Low density lipoprotein
Polycystic ovary syndrome
Pregnancy
Pregnant women
Prevention
Researchers
Review
Studies
Triglycerides
Type 2 diabetes
Vitamin B
Womens health
Online AccessGet full text

Cover

More Information
Summary:Gestational diabetes mellitus (GDM) is a complication that increasingly affects pregnant women. Due to the risk of adverse outcomes in the mother as well as in the fetus which is caused by GDM, appropriate diagnosis and treatment is very essential. Nevertheless, it is important to find new, effective ways of prevention of GDM to avoid side effects. A promising example of such an action may be supplementation of myoinositol. As shown in studies, myoinositol may reduce the risk of developing gestational diabetes mellitus by improving insulin sensitivity.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Academic Editor: Bernard Portha
ISSN:2314-6745
2314-6753
DOI:10.1155/2019/3915253